Abstract
Establishing the neural mechanisms responsible for the altered global states of consciousness during anesthesia and dissociating these from other drug-related effects remains a challenge in consciousness research. We investigated differences in brain activity between connectedness and disconnectedness by administering various anesthetics at concentrations designed to render 50% of the subjects unresponsive. One hundred and sixty healthy male subjects were randomized to receive either propofol (1.7 μg/ml; n = 40), dexmedetomidine (1.5 ng/ml; n = 40), sevoflurane (0.9% end-tidal; n = 40), S-ketamine (0.75 μg/ml; n = 20) or saline placebo (n = 20) for 60 min using target-controlled infusions or vaporizer with end-tidal monitoring. Disconnectedness was defined as unresponsiveness to verbal commands probed at 2.5 min intervals and unawareness of external events in a post-anesthesia interview. High-resolution positron emission tomography was used to quantify regional cerebral metabolic rates of glucose utilization. Contrasting scans where the subjects were classified as connected and responsive vs. disconnected and unresponsive revealed that for all anesthetics, except S-ketamine, the level of thalamic activity differed between these states. A conjunction analysis across the propofol, dexmedetomidine and sevoflurane groups confirmed the thalamus as the primary structure where reduced metabolic activity was related to disconnectedness. Widespread cortical metabolic suppression was observed when these subjects, classified as either connected or disconnected, were compared with the placebo group, suggesting that these findings may represent necessary but alone insufficient mechanisms for the change in the state of consciousness.
SIGNIFICANCE STATEMENT:
Experimental anesthesia is commonly used in the search for measures of brain function which could distinguish between global states of consciousness. However, most previous studies have not been designed to separate effects related to consciousness from other effects related to drug exposure. We employed a novel study design to disentangle these effects by exposing subjects to pre-defined EC50 doses of four commonly used anesthetics or saline placebo. We demonstrate that state-related effects are remarkably limited compared to the widespread cortical effects related to drug exposure. In particular, decreased thalamic activity was associated with disconnectedness with all used anesthetics except for S-ketamine.
Footnotes
M.S.: Consultancy and contract research relationships with Orion Pharma, the original manufacturer of dexmedetomidine. Orion Pharma was not involved in the planning or execution of the current study. M.S. was also listed as inventor in Orion Pharma's US Patent Application US5344840A from 1993, “4-substituted imidazole derivatives useful in perioperative care”, now expired. M.S. declares no current competing financial interests in the study. Other authors declare no competing financial interests.
The authors would like to thank the radiographers and anesthesia nurses at Turku PET Centre for excellent technical assistance and Ms. Saija Sirén, Lic. Phil., for the analysis of drug concentrations in plasma. This work was supported by Academy of Finland, Helsinki, Finland (grant numbers 266467, 266434); Jane and Aatos Erkko Foundation, Helsinki, Finland; VSSHP-EVO (grant numbers 13323, L3824), Turku, Finland; Doctoral Programme of Clinical Investigation, University of Turku Graduate School, Turku, Finland (O.K., A.S., L.R.); Paulo Foundation, Espoo, Finland (A.S.); Finnish Medical Foundation, Helsinki, Finland (O.K., A.S.); The Orion Research Foundation, Espoo, Finland (A.S.); Signe and Ane Gyllenberg Foundation (O.K.); Emil Aaltonen Foundation (O.K., L.L., R.E.K.)
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.